Hansoh Pharma Announces HKD 0.20 Final Dividend for FY2025, Payable on 24 July 2026

Bulletin Express03-29

Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has declared a final ordinary dividend of HKD 0.20 per share for the financial year ended 31 December 2025, according to its latest filing with the Stock Exchange of Hong Kong.

Key distribution dates are as follows: • Ex-dividend date: 3 July 2026 • Last day to lodge share transfers: 6 July 2026 (16:30) • Book-closure period: 7–9 July 2026 • Record date: 9 July 2026 • Payment date: 24 July 2026

The dividend will be paid in Hong Kong dollars, with no currency conversion applicable (HKD 1 = HKD 1). The company stated that no withholding tax will be applied to the distribution. Payment will be administered by Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

Shareholder approval for the proposed final dividend is pending, with the meeting date to be announced. The board of directors currently comprises Chairlady and Executive Director Ms. Zhong Huijuan, Executive Directors Ms. Sun Yuan and Dr. Lyu Aifeng, and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Charles Sheung Wai, Ms. Yang Dongtao and Mr. Yan Jia.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187198661?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-29 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187198661","market":"us","top_or_hot":-1,"title":"Hansoh Pharma Announces HKD 0.20 Final Dividend for FY2025, Payable on 24 July 2026","media":"Bulletin Express","content":"<p>Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has declared a final ordinary dividend of HKD 0.20 per share for the financial year ended 31 December 2025, according to its latest filing with the Stock Exchange of Hong Kong.</p>\n<p>Key distribution dates are as follows:\n• Ex-dividend date: 3 July 2026  \n• Last day to lodge share transfers: 6 July 2026 (16:30)  \n• Book-closure period: 7–9 July 2026  \n• Record date: 9 July 2026  \n• Payment date: 24 July 2026</p>\n<p>The dividend will be paid in Hong Kong dollars, with no currency conversion applicable (HKD 1 = HKD 1). The company stated that no withholding tax will be applied to the distribution. Payment will be administered by Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>Shareholder approval for the proposed final dividend is pending, with the meeting date to be announced. The board of directors currently comprises Chairlady and Executive Director Ms. Zhong Huijuan, Executive Directors Ms. Sun Yuan and Dr. Lyu Aifeng, and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Charles Sheung Wai, Ms. Yang Dongtao and Mr. Yan Jia.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hansoh Pharma Announces HKD 0.20 Final Dividend for FY2025, Payable on 24 July 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHansoh Pharma Announces HKD 0.20 Final Dividend for FY2025, Payable on 24 July 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-29 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has declared a final ordinary dividend of HKD 0.20 per share for the financial year ended 31 December 2025, according to its latest filing with the Stock Exchange of Hong Kong.</p>\n<p>Key distribution dates are as follows:\n• Ex-dividend date: 3 July 2026  \n• Last day to lodge share transfers: 6 July 2026 (16:30)  \n• Book-closure period: 7–9 July 2026  \n• Record date: 9 July 2026  \n• Payment date: 24 July 2026</p>\n<p>The dividend will be paid in Hong Kong dollars, with no currency conversion applicable (HKD 1 = HKD 1). The company stated that no withholding tax will be applied to the distribution. Payment will be administered by Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>Shareholder approval for the proposed final dividend is pending, with the meeting date to be announced. The board of directors currently comprises Chairlady and Executive Director Ms. Zhong Huijuan, Executive Directors Ms. Sun Yuan and Dr. Lyu Aifeng, and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Charles Sheung Wai, Ms. Yang Dongtao and Mr. Yan Jia.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"","article_id":"1187198661","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187198661","pubTimestamp":1774784643,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has declared a final ordinary dividend of HKD 0.20 per share for the financial year ended 31 December 2025, according to its latest filing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药"},"translate_title":"翰森制药宣布派发2025财年末期股息0.20港元，将于2026年7月24日派发","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has declared a final ordinary dividend of HKD 0.20 per share for the financial year ended 31 December 2025, according to its latest filing with the Stock Exchange of Hong Kong.\nKey distribution dates are as follows:\n• Ex-dividend date: 3 July 2026  \n• Last day to lodge share transfers: 6 July 2026 (16:30)  \n• Book-closure period: 7–9 July 2026  \n• Record date: 9 July 2026  \n• Payment date: 24 July 2026\nThe dividend will be paid in Hong Kong dollars, with no currency conversion applicable (HKD 1 = HKD 1). The company stated that no withholding tax will be applied to the distribution. Payment will be administered by Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.\nShareholder approval for the proposed final dividend is pending, with the meeting date to be announced. The board of directors currently comprises Chairlady and Executive Director Ms. Zhong Huijuan, Executive Directors Ms. Sun Yuan and Dr. Lyu Aifeng, and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Charles Sheung Wai, Ms. Yang Dongtao and Mr. Yan Jia.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187198661","isCrawlerRequest":true}